GlassScriptPhysician profile
Keri M Mack
NPI 1578913992
$851.14
in general payments reported to CMS, 2019-2025
21 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $143 · 2023: $156 · 2024: $33.13 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $132.98 | 2023-2025 | Pylarify |
| Janssen Biotech, INC. | $125.61 | 2025 | Rybrevant, Carvykti |
| Boston Scientific Corporation | $103.86 | 2023-2025 | Axonics, Spaceoar System, Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $48.58 | 2023-2025 | Orgovyx |
| Astellas Pharma US INC | $48.28 | 2021 | |
| Blue Earth Diagnostics | $47.19 | 2021-2022 | |
| Urovant Sciences INC | $45.62 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $44.30 | 2022 | |
| Laborie Medical Technologies Corp. | $30.68 | 2021-2024 | |
| Myovant Sciences INC. | $27.39 | 2021-2022 | |
| Endo USA, INC. | $24.06 | 2025 | Xiaflex, Edex, Aveed |
| Dendreon Pharmaceuticals LLC | $23.92 | 2025 | Provenge |
| Axonics, INC. | $19.47 | 2021 | |
| Bluewind Medical | $19.31 | 2025 | |
| Antares Pharma, INC. | $18.61 | 2025 | Xyosted |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $18.20 | 2021 | |
| Acerus Pharmaceuticals Corporation | $18.11 | 2021 | |
| Coloplast Corp | $16.69 | 2023 | Speedicath |
| Mission Pharmacal Company | $13.38 | 2021 | |
| Abbvie INC. | $12.92 | 2022 | |
| Myriad Genetic Laboratories, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keri Mack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.